Oculus Innovative Sciences Inc. (NASDAQ:OCLS) was down 4.6% on Monday . The company traded as low as $4.11 and last traded at $4.12, with a volume of 67,342 shares trading hands. The stock had previously closed at $4.32.

A number of equities research analysts have weighed in on OCLS shares. Zacks Investment Research downgraded Oculus Innovative Sciences from a “hold” rating to a “sell” rating in a research report on Wednesday, March 16th. Maxim Group restated a “buy” rating and set a $3.00 price target on shares of Oculus Innovative Sciences in a research report on Wednesday, April 20th.

The stock’s market cap is $17.34 million. The firm’s 50 day moving average price is $4.61 and its 200-day moving average price is $4.98.

Oculus Innovative Sciences (NASDAQ:OCLS) last issued its quarterly earnings data on Thursday, June 16th. The company reported ($0.16) earnings per share (EPS) for the quarter. Analysts forecast that Oculus Innovative Sciences Inc. will post ($0.37) EPS for the current fiscal year.

Oculus Innovative Sciences, Inc is a specialty device and pharmaceutical company. The Company develops and markets solutions for the treatment of dermatological conditions and advanced tissue care in both humans and animals. The Company offers wound care products which are sold into the human and animal healthcare markets in the United States, Mexico and Europe.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.